Patent ID: 11857617
Assignee: TOPELIA AUST LIMITED (652 771 670)
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 16:
17. The method of claim 1, wherein at least one dosage of the anti-viral drug combination is administered 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 or more days before, or on the day of, and/or is administered 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 or more days after, a first dose of the live, inactivated or attenuated causative agent of the infection.